Ba Duan Jin for Depression and Anxiety
A Pilot Study of Ba Duan Jin for Depression and Anxiety
1 other identifier
interventional
59
1 country
1
Brief Summary
In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the present study is to examine the effects of Ba Duan Jin on reducing symptoms of depression or anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2019
CompletedFirst Submitted
Initial submission to the registry
December 8, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2024
CompletedApril 2, 2025
March 1, 2025
3.6 years
December 8, 2020
March 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
17-item Hamilton Depression Rating Scale
The HAMD-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression.
Change from Baseline HAMD-17 at 16 weeks
14-item Hamilton Anxiety Rating Scale
The HAMA-14 is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety.
Change from Baseline HAMA-14 at 16 weeks
Secondary Outcomes (7)
Depression, Anxiety and Stress Scale-21 item
Baseline
Depression, Anxiety and Stress Scale-21 item
8 weeks
Depression, Anxiety and Stress Scale-21 item
16 weeks
Gut microbiota
Baseline
Gut microbiota
16 weeks
- +2 more secondary outcomes
Study Arms (2)
Ba Duan Jin Group
EXPERIMENTALBa Duan Jin plus health education. Participants take part in 16-week program. The health education is conducted as the Health Education Group. Besides, the participants attended two 90-minute sessions of group-based Ba Duan Jin training per week and practiced at least three 30-minute Ba Duan Jin sessions at home per day.
Health Education Group
ACTIVE COMPARATORHealth education. Participants take part in 16-week program. The health education includes work, rest, diet and other basic programs according to the different conditions of participants.
Interventions
Ba Duan Jin, a traditional Chinese health-preserving technique, combines techniques regulating body, breath and spirit. According to traditional Chinese theory, every movement of Ba Duan Jin has unique effect to different Zang-fu organs.
Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.
Eligibility Criteria
You may qualify if:
- Subject with depression or anxiety symptom diagnosed by ICD-10.
- Subject is male or female, age 18 to 75.
- Subject has a clear mind and the ability to read, to talk and to communicate.
- Subject agrees to participate in this study and sign to the informed consent
You may not qualify if:
- Subject has severe somatic disease.
- Subject has history of organic mental disorder, epilepsy, schizophrenia.
- Subject takes any medication of food having effect on gut microbiota within 1 month of screening.
- Subject has history of alcohol abuse.
- Subject is pregnant, lactating or breast-feeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Qigong Research Institute
Shanghai, Shanghai Municipality, 021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study was a single-blind controlled trial in which the outcome assessor was blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate
Study Record Dates
First Submitted
December 8, 2020
First Posted
December 17, 2020
Study Start
April 10, 2019
Primary Completion
October 31, 2022
Study Completion
February 4, 2024
Last Updated
April 2, 2025
Record last verified: 2025-03